2型糖尿病患者预混胰岛素类似物治疗与持续胰岛素输注治疗剂量的相关性研究
Correlation between the dosage of premixed insulin analogue treatment and continuous subcutaneous insulin infusion treatment in type 2 diabetes
摘要分析经短期持续皮下胰岛素输注(CSII)强化治疗后换为预混胰岛素类似物治疗的2型糖尿病患者,发现CSII治疗末日胰岛素使用量小于45 U/d宜选择每日2次预混胰岛素类似物治疗,大于45 U/d 宜选择每日3次预混胰岛素类似物治疗.其治疗剂量可根据以下方程:每日2次预混胰岛素类似物治疗剂量=13.093+0.395×CSII治疗总量,每日3次预混胰岛素类似物治疗剂量=23.114+0.405×CSII治疗总量.
更多相关知识
abstractsTo observe the patients with type 2 diabetes who were injected premixed insulin analogues after short time continuous subcutaneous insulin infusion( CSII ) treatment.It was found that the patients needed premixed insulin analogue injection 2 times daily when the dosage of CSII was less than 45 U/d,and 3 times daily when the dosage was greater than 45 U/d.The relationship of dosages between premixed insulin analogue treatment ( Y ) and CSII treatment(X) was calculated by following equations:2 times daily premixed insulin analogue treatment:Y =13.093 +0.395X,3 times daily premixed insulin analogue treatment:Y =23.114+0.405X.
More相关知识
- 浏览351
- 被引8
- 下载232

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



